Overexpression of microRNA-21 is associated with elevated pro-inflammatory cytokines in dominant-negative TGF-β receptor type II mouse

Journal of Autoimmunity

Volumn 41, Issue , 2013, Pages 111-119

  Ando, Yugo ^a,b   Yang, Guo Xiang ^a   Kenny, Thomas P ^a   Kawata, Kazuhito ^a   Zhang, Weici ^a   Huang, Wenting ^c   Leung, Patrick S C ^a   Lian, Zhe Xiong ^a,d   Okazaki, Kazuichi ^b   Ansari, Aftab A ^e   He, Xiao Song ^a   Invernizzi, Pietro ^a,f   Ridgway, William M ^c   Lu, Qianjin ^g   Gershwin, M Eric ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^d UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^e EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF MILAN   (Italy)

^g CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Autoimmunity; Cholangitis; Colitis; Inflammatory bowel disease; MicroRNA; MiR 21; Primary biliary cirrhosis

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 6; MICRORNA 21; PROGRAMMED CELL DEATH PROTEIN 4; PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHOLANGITIS; COLITIS; MESENTERY LYMPH NODE; MONONUCLEAR CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SPLEEN; UPREGULATION;

ANIMALS; APOPTOSIS REGULATORY PROTEINS; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CHOLANGITIS; CYTOKINES; FLOW CYTOMETRY; GENE EXPRESSION; HUMANS; INFLAMMATION MEDIATORS; INTERFERON-GAMMA; INTERLEUKIN-17; LIVER; LIVER CIRRHOSIS, BILIARY; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICRORNAS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS;

EID: 84875917033     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2012.12.013     Document Type: Article

References (48)

1. Gorelik L., Flavell R.A. Abrogation of TGFbeta signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 2000, 12:171-181.
2. Yang G.X., Lian Z.X., Chuang Y.H., Moritoki Y., Lan R.Y., Wakabayashi K., et al. Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice. Hepatology 2008, 47:1974-1982.
3. Zhang W., Tsuda M., Yang G.X., Tsuneyama K., Rong G., Ridgway W.M., et al. Deletion of interleukin-6 in mice with the dominant negative form of transforming growth factor beta receptor II improves colitis but exacerbates autoimmune cholangitis. Hepatology 2010, 52:215-222.
4. Ando Y., Yang G.X., Tsuda M., Kawata K., Zhang W., Nakajima T., et al. The immunobiology of colitis and cholangitis in IL-23p19 and IL-17A deleted dnTGFbetaRII mice. Hepatology 2012, 56:1418-1426.
5. Tsuda M., Zhang W., Yang G.X., Tsuneyama K., Ando Y., Kawata K., et al. Deletion of IL-12p35 induces liver fibrosis in dominant negative transforming growth factor beta receptor type II mice. Hepatology 2012.
6. Nelson P., Kiriakidou M., Sharma A., Maniataki E., Mourelatos Z. The microRNA world: small is mighty. Trends Biochem Sci 2003, 28:534-540.
7. Carthew R.W., Sontheimer E.J. Origins and mechanisms of miRNAs and siRNAs. Cell 2009, 136:642-655.
8. O'Hara S.P., Mott J.L., Splinter P.L., Gores G.J., LaRusso N.F. MicroRNAs: key modulators of posttranscriptional gene expression. Gastroenterology 2009, 136:17-25.
9. Pauley K.M., Cha S., Chan E.K. MicroRNA in autoimmunity and autoimmune diseases. J Autoimmun 2009, 32:189-194.
10. Nakasa T., Miyaki S., Okubo A., Hashimoto M., Nishida K., Ochi M., et al. Expression of microRNA-146 in rheumatoid arthritis synovial tissue. Arthritis Rheum 2008, 58:1284-1292.
11. Stanczyk J., Pedrioli D.M., Brentano F., Sanchez-Pernaute O., Kolling C., Gay R.E., et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 2008, 58:1001-1009.
12. Dai Y., Huang Y.S., Tang M., Lv T.Y., Hu C.X., Tan Y.H., et al. Microarray analysis of microRNA expression in peripheral blood cells of systemic lupus erythematosus patients. Lupus 2007, 16:939-946.
13. Davis B.N., Hilyard A.C., Lagna G., Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454:56-61.
14. Davis B.N., Hilyard A.C., Nguyen P.H., Lagna G., Hata A. Smad proteins bind a conserved RNA sequence to promote microRNA maturation by Drosha. Mol Cell 2010, 39:373-384.
15. Hata A., Davis B.N. Control of microRNA biogenesis by TGFbeta signaling pathway-A novel role of Smads in the nucleus. Cytokine Growth Factor Rev 2009, 20:517-521.
16. Oertelt S., Lian Z.X., Cheng C.M., Chuang Y.H., Padgett K.A., He X.S., et al. Anti-mitochondrial antibodies and primary biliary cirrhosis in TGF-beta receptor II dominant-negative mice. J Immunol 2006, 177:1655-1660.
17. Yoshida K., Yang G.X., Zhang W., Tsuda M., Tsuneyama K., Moritoki Y., et al. Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice. Hepatology 2009, 50:1494-1500.
18. Yang G.X., Lian Z.X., Kikuchi K., Liu Y.J., Ansari A.A., Ikehara S., et al. CD4-plasmacytoid dendritic cells (pDCs) migrate in lymph nodes by CpG inoculation and represent a potent functional subset of pDCs. J Immunol 2005, 174:3197-3203.
19. Lian Z.X., Okada T., He X.S., Kita H., Liu Y.J., Ansari A.A., et al. Heterogeneity of dendritic cells in the mouse liver: identification and characterization of four distinct populations. J Immunol 2003, 170:2323-2330.
20. Moritoki Y., Zhang W., Tsuneyama K., Yoshida K., Wakabayashi K., Yang G.X., et al. B cells suppress the inflammatory response in a mouse model of primary biliary cirrhosis. Gastroenterology 2009, 136:1037-1047.
21. Yang G.X., Wu Y., Tsukamoto H., Leung P.S., Lian Z.X., Rainbow D.B., et al. CD8 T cells mediate direct biliary ductule damage in nonobese diabetic autoimmune biliary disease. J Immunol 2011, 186:1259-1267.
22. Ng R., Song G., Roll G.R., Frandsen N.M., Willenbring H. A microRNA-21 surge facilitates rapid cyclin D1 translation and cell cycle progression in mouse liver regeneration. J Clin Invest 2012, 122:1097-1108.
23. Garbacki N., Di Valentin E., Huynh-Thu V.A., Geurts P., Irrthum A., Crahay C., et al. MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets. PLoS One 2011, 6:e16509.
24. Olson T.S., Bamias G., Naganuma M., Rivera-Nieves J., Burcin T.L., Ross W., et al. Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. J Clin Invest 2004, 114:389-398.
25. Kim G., Levin M., Schoenberger S.P., Sharpe A., Kronenberg M. Paradoxical effect of reduced costimulation in T cell-mediated colitis. J Immunol 2007, 178:5563-5570.
26. Lovendorf M.B., Zibert J.R., Hagedorn P.H., Glue C., Odum N., Ropke M.A., et al. Comparison of microRNA expression using different preservation methods of matched psoriatic skin samples. Exp Dermatol 2012, 21:299-301.
27. Pan W., Zhu S., Yuan M., Cui H., Wang L., Luo X., et al. MicroRNA-21 and microRNA-148a contribute to DNA hypomethylation in lupus CD4+ T cells by directly and indirectly targeting DNA methyltransferase 1. J Immunol 2010, 184:6773-6781.
28. Ruan Q., Wang T., Kameswaran V., Wei Q., Johnson D.S., Matschinsky F., et al. The microRNA-21-PDCD4 axis prevents type 1 diabetes by blocking pancreatic beta cell death. Proc Natl Acad Sci U S A 2011, 108:12030-12035.
29. Wu F., Zikusoka M., Trindade A., Dassopoulos T., Harris M.L., Bayless T.M., et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory peptide-2 alpha. Gastroenterology 2008, 135. 1624.e24-1635.e24.
30. Wu F., Zhang S., Dassopoulos T., Harris M.L., Bayless T.M., Meltzer S.J., et al. Identification of microRNAs associated with ileal and colonic Crohn's disease. Inflamm Bowel Dis 2010, 16:1729-1738.
31. Schaefer J.S., Montufar-Solis D., Vigneswaran N., Klein J.R. Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/- mice precedes expression in the colon. J Immunol 2011, 187:5834-5841.
32. Fujita S., Ito T., Mizutani T., Minoguchi S., Yamamichi N., Sakurai K., et al. miR-21 Gene expression triggered by AP-1 is sustained through a double-negative feedback mechanism. J Mol Biol 2008, 378:492-504.
33. Niu J., Shi Y., Tan G., Yang C.H., Fan M., Pfeffer L.M., et al. DNA damage induces NF-κB-dependent microRNA-21 upregulation and promotes breast cancer cell invasion. J Biol Chem 2012, 287:21783-21795.
34. Sheedy F.J., Palsson-McDermott E., Hennessy E.J., Martin C., O'Leary J.J., Ruan Q., et al. Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 2010, 11:141-147.
35. Bourguignon L.Y., Earle C., Wong G., Spevak C.C., Krueger K. Stem cell marker (Nanog) and Stat-3 signaling promote MicroRNA-21 expression and chemoresistance in hyaluronan/CD44-activated head and neck squamous cell carcinoma cells. Oncogene 2012, 31:149-160.
36. Chen F., Castranova V., Shi X., Demers L.M. New insights into the role of nuclear factor-kappaB, a ubiquitous transcription factor in the initiation of diseases. Clin Chem 1999, 45:7-17.
37. Baldwin A.S. The NF-kappa B and I kappa B proteins: new discoveries and insights. Annu Rev Immunol 1996, 14:649-683.
38. Finco T.S., Baldwin A.S. Mechanistic aspects of NF-kappa B regulation: the emerging role of phosphorylation and proteolysis. Immunity 1995, 3:263-272.
39. Barnes P.J., Karin M. Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997, 336:1066-1071.
40. Smythies L.E., Shen R., Bimczok D., Novak L., Clements R.H., Eckhoff D.E., et al. Inflammation anergy in human intestinal macrophages is due to Smad-induced IkappaBalpha expression and NF-kappaB inactivation. J Biol Chem 2010, 285:19593-19604.
41. Haller D., Holt L., Kim S.C., Schwabe R.F., Sartor R.B., Jobin C. Transforming growth factor-beta 1 inhibits non-pathogenic Gram negative bacteria-induced NF-kappa B recruitment to the interleukin-6 gene promoter in intestinal epithelial cells through modulation of histone acetylation. J Biol Chem 2003, 278:23851-23860.
42. You H.J., How T., Blobe G.C. The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2. Carcinogenesis 2009, 30:1281-1287.
43. Asangani I.A., Rasheed S.A., Nikolova D.A., Leupold J.H., Colburn N.H., Post S., et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008, 27:2128-2136.
44. Zhu S., Wu H., Wu F., Nie D., Sheng S., Mo Y.Y. MicroRNA-21 targets tumor suppressor genes in invasion and metastasis. Cell Res 2008, 18:350-359.
45. Frankel L.B., Christoffersen N.R., Jacobsen A., Lindow M., Krogh A., Lund A.H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 2008, 283:1026-1033.
46. Stagakis E., Bertsias G., Verginis P., Nakou M., Hatziapostolou M., Kritikos H., et al. Identification of novel microRNA signatures linked to human lupus disease activity and pathogenesis: miR-21 regulates aberrant T cell responses through regulation of PDCD4 expression. Ann Rheum Dis 2011, 70:1496-1506.
47. Iliopoulos D., Kavousanaki M., Ioannou M., Boumpas D., Verginis P. The negative costimulatory molecule PD-1 modulates the balance between immunity and tolerance via miR-21. Eur J Immunol 2011, 41:1754-1763.
48. Wu H., Neilson J.R., Kumar P., Manocha M., Shankar P., Sharp P.A., et al. miRNA profiling of naïve, effector and memory CD8 T cells. PLoS One 2007, 2:e1020.